Medicine guide

Methotrexat Orion rheuma/derm 2.5 mg

As listed in the register: Methotrexat Orion rheuma/derm 2.5 mg, Tabletten

2.5 mg ·

  • Prescription only
  • Cancer treatments and immune-system medicines
Active substance
Methotrexatum
Made by
Orion Pharma AG

Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.

What it is for

  • Behandlung von Autoimmunerkrankungen wie z.B. rheumatoide Arthritis / Behandlung schwerer Fälle unkontrollierbarer Psoriasis, welche gegenüber konventioneller Therapie resistent sind

From the official label · 2026-09-30 · Swissmedic

Same active substance, strength and form in other countries

Matched on active substance, strength and kind of form only. This is not a statement that the products are equivalent or interchangeable: other ingredients, release and approved uses can differ — ask a pharmacist before swapping.

Medicine passport: one printable page to show a pharmacist abroad

BulgariaNo exact match for this strength and form

European UnionNo exact match for this strength and form

SpainNo exact match for this strength and form

CanadaNo exact match for this strength and form

NetherlandsNo exact match for this strength and form

Details

Made byOrion Pharma AG
Active substanceMethotrexatum
Used inCancer treatments and immune-system medicines
Strength2.5 mg
ClassificationL04AX03 · Cancer treatments and immune-system medicines
Dispensing (as stated by the register)Abgabekategorie A
Name in the registerMethotrexat Orion rheuma/derm 2.5 mg, Tabletten
Packs20 Tablette(n) · 20 Tablette(n)
Zulassungsnummer66019
Dosisstärke1

Source: Zugelassene Packungen Humanarzneimittel · 2026-09-30 · not reviewed by a clinician

Quelle: Swissmedic. The publisher’s terms do not grant reproduction, so text is shortened and linked. Publisher’s terms.

Same active substance

These contain the same substance. That does not mean one can replace another — ask a pharmacist.